Itraconazole and antiretroviral therapy: strategies for empirical dosing - Author's reply

Affiliations

¹ Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam.
² Centre d'Investigation Clinique Antilles Guyane, Inserm CIC1424, Centre Hospitalier de Cayenne, Cayenne, France.
³ Mayo Clinic College of Medicine, Rochester, MN, USA.
⁴ Institute of Infection and Immunity, St George's, University of London, London SW17 ORE, UK. Electronic address: tharriso@sgul.ac.uk.

Comment

Thuy Le et al. Lancet Infect Dis. 2017 Nov.

. 2017 Nov;17(11):1123-1124.

doi: 10.1016/S1473-3099(17)30582-0.

¹ Oxford University Clinical Research Unit, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam.
² Centre d'Investigation Clinique Antilles Guyane, Inserm CIC1424, Centre Hospitalier de Cayenne, Cayenne, France.
³ Mayo Clinic College of Medicine, Rochester, MN, USA.
⁴ Institute of Infection and Immunity, St George's, University of London, London SW17 ORE, UK. Electronic address: tharriso@sgul.ac.uk.

No abstract available

Comment on

Fungal infections in HIV/AIDS.
Limper AH, Adenis A, Le T, Harrison TS. Limper AH, et al. Lancet Infect Dis. 2017 Nov;17(11):e334-e343. doi: 10.1016/S1473-3099(17)30303-1. Epub 2017 Jul 31. Lancet Infect Dis. 2017. PMID: 28774701 Review.
Itraconazole and antiretroviral therapy: strategies for empirical dosing.
Schwartz IS, Wasserman S. Schwartz IS, et al. Lancet Infect Dis. 2017 Nov;17(11):1122-1123. doi: 10.1016/S1473-3099(17)30568-6. Lancet Infect Dis. 2017. PMID: 29115262 No abstract available.